Annaliesa S. Anderson
Annaliesa S. Anderson publishes mostly in Infectious Diseases, Epidemiology and Microbiology, on topics such as Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections and SARS-CoV-2 and COVID-19 Research.
- World rank
- #74,192 of 7,710,434 ranked researchers
- Rank in United States
- #28,655 of 1,627,098
- Works
- 263
- Citations
- 13k
- Citations per work
- 49.7
What does Annaliesa S. Anderson research?
Annaliesa S. Anderson's work is mostly in Medicine (54%), Immunology and Microbiology (15%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences14354.5%
- Medicine14354.5%
- Life Sciences6022.9%
- Everything else5922.6%
- 1Infectious Diseases26% of their works
- 2Epidemiology22% of their works
- 3Microbiology9% of their works
- 4Molecular Biology8% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Immunology5% of their works
Research topics
Which keywords describe Annaliesa S. Anderson's research?
The keywords of their largest research topics: Epidemiology, Immunity, Vaccine, Clinical Management, Antimicrobial Resistance, ACE2 Receptor, SARS-CoV-2 and Bacterial Meningitis.
- Group B Streptococcus
- Clinical Characteristics
- Bacteria
- Human Metapneumovirus
- MRSA
- Coronavirus
- Community-Acquired Pneumonia
- Bacterial Meningitis
- ACE2 Receptor
- Clinical Management
- Immunity
- Epidemiology
- Vaccine
- Antimicrobial Resistance
- SARS-CoV-2
- Neisseria meningitidis
- Pneumococcal Conjugate Vaccine
- spike protein
- Staphylococcus aureus
- Respiratory Syncytial Virus
- Biofilms
- Thrombosis
- Neonatal Sepsis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Epidemiology2385 topics
- Immunity1212 topics
- Vaccine1212 topics
- Clinical Management1152 topics
- Antimicrobial Resistance1102 topics
- ACE2 Receptor812 topics
- SARS-CoV-2812 topics
- Bacterial Meningitis641 topic
- Neisseria meningitidis641 topic
- Community-Acquired Pneumonia591 topic
- Pneumococcal Conjugate Vaccine591 topic
- Coronavirus571 topic
- spike protein571 topic
- MRSA511 topic
- Staphylococcus aureus511 topic
- Human Metapneumovirus401 topic
- Respiratory Syncytial Virus401 topic
- Bacteria241 topic
- Biofilms241 topic
- Clinical Characteristics241 topic
- Thrombosis241 topic
- Group B Streptococcus231 topic
- Neonatal Sepsis231 topic
Where does Annaliesa S. Anderson work?
Annaliesa S. Anderson's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Annaliesa S. Anderson have?
OpenAlex counts 263 works and 13,083 citations for Annaliesa S. Anderson, an h-index of 55, ranking #74,192 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Annaliesa S. Anderson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.